ZKIN vs ZEUS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

ZKIN

57.0
AI Score
VS
ZKIN Wins

ZEUS

46.5
AI Score

Investment Advisor Scores

ZKIN

57score
Recommendation
HOLD

ZEUS

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ZKIN ZEUS Winner
Forward P/E 0 13.1234 Tie
PEG Ratio 0 0.46 Tie
Revenue Growth -43.5% 4.4% ZEUS
Earnings Growth -97.7% -21.7% ZEUS
Tradestie Score 57.0/100 46.5/100 ZKIN
Profit Margin -28.0% 0.7% ZEUS
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ZKIN 1M: -10.9% · 3M: +42.4% ZEUS 1M: -0.4% · 3M: +39.7%

Current Technical Phase

ZKIN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (12.2% over 20 days), RSI 51

RSI (14): 50.7 · Price: $1.55

ZEUS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.4 · Price: $47.86

Fundamentals Snapshot

Metric ZKIN ZEUS
Market Cap — —
Forward P/E 0.0 21.0
Trailing P/E — 41.7
Revenue (TTM) — —
Revenue Growth -0.4% 0.0%
Gross Margin 0.1% 0.2%
Operating Margin -8.0% 0.0%
EPS -1.44 1.22
Dividend Yield — 0.01%

Frequently Asked Questions

Based on our detailed analysis, ZKIN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.